Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Ideas Moving Parents and Adolescents to Change Together (IMPACT) (IMPACT)

13 de agosto de 2020 atualizado por: Elaine Borawski, Case Western Reserve University

Targeting Obesity and Blood Pressure in Urban Youth(Consortium Title: Childhood Obesity Prevention and Treatment Research [COPTR] and Site Project Name IMPACT (Ideas Moving Parents and Adolescents to Change Together).

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institute of Health (NIH) has sponsored a consortium of four sites across the United States, entitled Childhood Obesity Prevention and Treatment Research (COPTR). Each site has its own protocol. Case Western Reserve/Cleveland's project is entitled "Targeting Obesity and Blood Pressure in Urban Youth". The site name is IMPACT (Ideas Moving Parents and Adolescents to Change Together).

The project assesses the effects of three interventions on Body Mass Index(BMI) in overweight and obese urban 5th-8th grade youth: a cognitive-behavioral intervention (HealthyChange), a systems improvement intervention (SystemsChange), and an education-only intervention (Tools4Change). In addition the study assesses the potential additional impact of a school-community based intervention on outcomes.

The project has two phases: a formative phase (including focus groups and a pilot) and the main trial. The main trial will take place over approximately four years.

Visão geral do estudo

Status

Concluído

Condições

Descrição detalhada

The IMPACT trial will involve a 3-arm randomized controlled trial of three behavioral and educational interventions: (1) HealthyCHANGE, a behavioral approach focusing on building skills and increasing intrinsic motivation (based on cognitive-behavioral theory with motivational interviewing components); (2) SystemCHANGE, an innovative behavioral approach focusing on system re-design of the family environment and daily routines (based on social-ecological and personal process improvement theories); and (3) education-only (representing usual care, called Tools4CHANGE).

In the main trial, approximately half of the children will also be in schools that take part in the We Run This City (WRTC)Marathon program, a school-based fitness program administered by the YMCA, and half will be in schools that do not take part in the WRTC program.

This study will assess the impact of the interventions on the main trial's (1) primary outcome, Change in Body Mass Index (BMI). (2) secondary outcomes including diet, physical activity, sedentary behavior, sleep, blood pressure, cardiovascular risk, body composition, fitness, and quality of life (3) mediators including : child's self-efficacy, social support, motivation, family problem solving ability, systems thinking, and self-regulation;(4) moderators including: socioeconomic status, demographic factors, environmental factors, personal and psychosocial characteristics of child and parent.

Tipo de estudo

Intervencional

Inscrição (Real)

360

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Ohio
      • Cleveland, Ohio, Estados Unidos, 44106
        • Case Western Reserve University

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

11 anos a 15 anos (Filho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Students entering the 6th grade who are found at the standard school screenings to be overweight or obese
  • (BMI 85th- 94th percentile or > 95th percentile for age/sex respectively)

Exclusion Criteria:

  • Taking medications that alter appetite or weight (e.g. glucocorticoids, metformin, insulin, Risperidone (Risperdal), Olanzapine (Zyprexa), Clozapine(Clozaril), Quetiapine (Seroquel), Ziprasidone (Geodon), Carbamazepine (Tegretol), Valproic acid (Depakote/Depakene/Depacon), Aripiprazole (Abilify), Orlistat (Xenical), Sibutramine (Meridia), Phentermine, Diethylproprion (Tenuate), Topirimate (Topamax), glitazones (thiazolidinediones)
  • Inability to understand English
  • Stage 2 hypertension or stage 1 hypertension with end organ damage (left ventricular hypertrophy, microalbuminuria)
  • Severe behavioral problems that preclude group participation (as reported by parent/guardian)
  • Child involvement in another weight management program
  • Family expectation to move from the region within 1 year
  • The presence of a known medical condition that itself causes obesity (e.g., Prader-Willi syndrome) or interfere with HbA1C ( sickle cell disease)

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: HealthyCHANGE
Cognitive behavioral strategies to address diet, physical activity, sedentary behavior and sleep for children.

Cognitive behavioral strategies to address diet, physical activity, sedentary behavior and sleep for children.

It involves an intensive series of group sessions, followed by rotating monthly face-to-face meetings or phone calls.

Experimental: SystemCHANGE
Intervention (based on systems improvement and choice architecture theories) System improvement and choice architecture theories seek to teach a set of skills using family self-designed experiments to redesign daily routines

Intervention (based on systems improvement and choice architecture theories) System improvement and choice architecture theories seek to teach a set of skills using family self-designed experiments to redesign daily routines regarding eating, activity and sleep.

It involves an intensive series of group sessions, followed by rotating monthly face-to-face meetings or phone calls.

Sem intervenção: Tools4CHANGE
In contrast to the behavioral arms, youths with their parent(s)/guardian randomized to this group will have one 60-minute face-to-face meeting at initiation of the study with a dietitian who is also trained in recommendations for exercise and sedentary behavior.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Slope of Body Mass Index (BMI)
Prazo: Baseline, 12 mos, 24 mos and 36 mos
BMI slope (trajectory over 3 years) was created for each participant with outcomes multiply imputed for children without BMI values post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.
Baseline, 12 mos, 24 mos and 36 mos

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Dietary Intake- Calories Per Day
Prazo: Baseline, 12 mos, 24 mos and 36 mos

Annualized change in calories per day.

Dietary intake slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without diet recall data post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 mos, 24 mos and 36 mos
Blood Pressure
Prazo: Baseline, 12 mos, 24 mos and 36 mos

Annualized change in blood pressure measures using the slope of 3 year trajectory.

Blood pressure slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood pressure readings post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 mos, 24 mos and 36 mos
Physical Activity
Prazo: [Baseline, 12 mos, 24 mos and 36 mos]

Annualized change in physical activity measures of moderate to vigorous minutes per day and bed rest/sedentary minutes per day as measured by accelerometer.

Physical activity slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without accelerometer readings post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

[Baseline, 12 mos, 24 mos and 36 mos]
Sleep
Prazo: [Baseline, 12 mos, 24 mos and 36 mos]

The results reflect the annualized change in adolescent sleep wake scale and pediatric daytime sleepiness scale. The items of the adolescent sleep wake scale are recoded to have a minimum of 0 and maximum value of 5, in which a higher scores for both the individual items and the overall sum score indicate a better outcome. The items of the pediatric daytime sleepiness are recoded to have a minimum of 0 and maximum value of 4, in which a lower score for both the individual items and the overall sum score indicates a better outcome.

Sleep slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without post-baseline measures. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

[Baseline, 12 mos, 24 mos and 36 mos]
Cardiometabolic Factors- Fasting Glucose, HDL Cholesterol, LDL Cholesterol, Total Cholesterol
Prazo: Baseline, 12 mos, 24 mos and 36 mos

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slopes of fasting glucose, HDL cholesterol, LDL cholesterol, and total cholesterol over 3 years reported.

Baseline, 12 mos, 24 mos and 36 mos
Body Composition- BMI Percentile
Prazo: Baseline, 12 mos, 24 mos and 36 mos

The annualized change in body composition measures over 3 years.

Body composition slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without body composition measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in slope of BMI percentile over time reported.

Baseline, 12 mos, 24 mos and 36 mos
Fitness
Prazo: Baseline, 12 mos, 24 mos and 36 mos

The annualized change in pacer laps completed during PACER test over 3 years.

PACER test slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without PACER test measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 mos, 24 mos and 36 mos
Quality of Life- Perceived Stress
Prazo: [Baseline, 12 mos, 24 mos and 36 mos]

The annualized change in perceived stress over 3 years. Participants are asked to rate individual scale items on their perception of how often they feel specific stressors on a scale from 0 (never) to 4 (very often). Individual scale items are summed for a total score. Higher scores indicate higher perceived frequency of stressors, therefore higher perceived stress. Outcomes are reported as the mean of the slope estimates for total perceived stress score over 3 years (from baseline to 36 months).

The perceived stress slope (trajectory over 3 years) was created for each participant with outcomes multiply imputed for children without stress scores post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

[Baseline, 12 mos, 24 mos and 36 mos]
Dietary Intake- Percent Calories From Fat
Prazo: Baseline, 12 months, 24 months, 36 months

The annualized change of percent of calories from fat over 3 years.

Percent calories from fat slope (trajectory over 3 years) was created for each participant with outcomes multiply imputed for children without diet recall data post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 months, 24 months, 36 months
Dietary Intake- Fruit and Vegetable Servings
Prazo: Baseline, 12 months, 24 months, 36 months

The annualized change in the number of fruit and vegetable servings per day over 3 years.

Serving slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without diet recall data post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 months, 24 months, 36 months
Dietary Intake- Sodium
Prazo: Baseline, 12 months, 24 months, 36 months

The annualized change in sodium intake (mg) per day over 3 years.

Sodium intake slope (trajectory over 3 years) was created for each participant with outcomes multiply imputed for children without diet recall data post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 months, 24 months, 36 months
Cardiometabolic Factors- Hemoglobin A1c
Prazo: [Baseline, 12 mos, 24 mos, 36 mos]

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slope of glycated Hemoglobin A1c over 3 years reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Cardiometabolic Factors- High-sensitivity C-reactive Protein
Prazo: [Baseline, 12 mos, 24 mos, 36 mos]

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slope of high-sensitivity C-reactive protein over 3 years reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Cardiometabolic Factors- Insulin
Prazo: [Baseline, 12 mos, 24 mos, 36 mos]

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slope of insulin over 3 years reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Cardiometabolic Factors- HOMA-IR
Prazo: [Baseline, 12 mos, 24 mos, 36 mos]

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slope of HOMA-IR over 3 years reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Body Composition- Waist-to-height Ratio
Prazo: [Baseline, 12 mos, 24 mos, 36 mos]

The annualized change in body composition measures over 3 years.

Body composition slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without body composition measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in slope of waist-to-height ratio over time reported. The weight-to-heigh ratio compares the child's waist circumference (cm) to their height (cm).

[Baseline, 12 mos, 24 mos, 36 mos]
Body Composition- Waist Circumference
Prazo: [Baseline, 12 mos, 24 mos, 36 mos]

The annualized change in body composition measures over 3 years.

Body composition slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without body composition measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in slope of waist circumference (cm) over time reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Body Composition- Percent Body Fat
Prazo: [Baseline, 12 mos, 24 mos, 36 mos]

The annualized change in body composition measures over 3 years.

Body composition slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without body composition measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in slope of body fat percentage over time reported. Body fat percentage calculated using Stevens equation.

[Baseline, 12 mos, 24 mos, 36 mos]

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Elaine A Borawski, PhD, Case Western Reserve University
  • Investigador principal: Shirley M Moore, RN, PhD, Case Western Reserve University

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de fevereiro de 2011

Conclusão Primária (Real)

21 de janeiro de 2017

Conclusão do estudo (Real)

31 de janeiro de 2017

Datas de inscrição no estudo

Enviado pela primeira vez

20 de dezembro de 2011

Enviado pela primeira vez que atendeu aos critérios de CQ

17 de janeiro de 2012

Primeira postagem (Estimativa)

23 de janeiro de 2012

Atualizações de registro de estudo

Última Atualização Postada (Real)

25 de agosto de 2020

Última atualização enviada que atendeu aos critérios de controle de qualidade

13 de agosto de 2020

Última verificação

1 de agosto de 2020

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • IMPACT-1-5U01HL103622-02
  • 5U01HL103622-02 (Concessão/Contrato do NIH dos EUA)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

Sim

Descrição do plano IPD

Conducted in conjunction with the Research Coordinating Unit (UNC Chapel Hill) of the COPTR Consortium.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

3
Se inscrever